Double maintains 10 strategies that include DHR - Danaher Corp.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BTCT | 0.20% | $18.98M | +37.85% | 0.00% |
TGI | 0.35% | $2.00B | +67.36% | 0.00% |
VSA | 0.55% | $8.67M | -15.70% | 0.00% |
CCRN | 0.71% | $419.30M | -7.59% | 0.00% |
PPC | -0.77% | $10.57B | +30.66% | 0.00% |
VHC | 0.99% | $45.90M | +59.26% | 0.00% |
PULM | 1.10% | $25.57M | +262.69% | 0.00% |
CNK | -1.10% | $3.46B | +39.22% | 0.53% |
STG | -1.12% | $29.06M | -28.79% | 0.00% |
TMUS | 1.37% | $267.11B | +33.53% | 1.40% |
ALHC | 1.56% | $2.74B | +77.11% | 0.00% |
ED | 1.59% | $35.36B | +9.76% | 3.39% |
AQB | 1.64% | $2.84M | -54.35% | 0.00% |
GORV | 1.75% | $25.03M | -91.07% | 0.00% |
HIHO | 1.76% | $7.53M | -17.39% | 4.00% |
UFI | 1.84% | $96.21M | -11.04% | 0.00% |
LRN | -1.91% | $6.34B | +106.55% | 0.00% |
K | -1.94% | $27.41B | +36.96% | 2.88% |
DFDV | -1.94% | $247.94M | +1,821.34% | 0.00% |
GFI | 2.02% | $20.47B | +53.49% | 2.38% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
RSPH | 73.68% | $731.31M | 0.4% |
VHT | 71.64% | $15.31B | 0.09% |
MOAT | 71.62% | $12.59B | 0.47% |
FHLC | 71.61% | $2.43B | 0.084% |
IYH | 70.69% | $2.71B | 0.39% |
FBT | 70.40% | $1.01B | 0.54% |
IBB | 69.40% | $5.36B | 0.45% |
XLV | 69.37% | $34.14B | 0.09% |
FXH | 69.36% | $898.02M | 0.62% |
BBH | 69.07% | $329.82M | 0.35% |
IXJ | 68.25% | $3.74B | 0.41% |
DSTL | 65.94% | $1.78B | 0.39% |
IUSV | 65.62% | $20.73B | 0.04% |
GNOM | 65.57% | $44.43M | 0.5% |
SPYV | 65.52% | $26.50B | 0.04% |
VOOV | 65.48% | $5.43B | 0.1% |
IVE | 65.39% | $38.74B | 0.18% |
PBE | 65.35% | $223.24M | 0.58% |
XLB | 65.35% | $5.32B | 0.09% |
RSP | 65.02% | $71.34B | 0.2% |
Yahoo
The company said Stumpe’s promotion is a “pivotal step in [its] digital transformation and its ambition to lead the next era of innovation in life sciences and diagnostics.”
SeekingAlpha
Danaher is positioned for a revenue rebound, led by strong bioprocessing demand and resilient recurring sales. Read why DHR stock is a Buy.
Yahoo
Growing at a decent rate and available at reasonable valuations.
Yahoo
Danaher Corporation (NYSE:DHR) is one of the 11 stocks Jim Cramer put under the microscope recently. Highlighting the company’s history of good acquisitions and strength during uncertain times, a caller asked about the company. In response, Cramer said: “I am horrified about what’s happening at Danaher. Everything you said is true, but the CEO, Rainer […]
MarketWatch
Danaher Corp. stock underperforms Friday when compared to competitors
Yahoo
CVS vs. DHR: Which Stock Is the Better Value Option?
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MSIF | -25.53% | $769.00M | +36.08% | 6.63% |
CBOE | -7.19% | $23.98B | +34.66% | 1.10% |
KR | -5.80% | $47.56B | +43.04% | 1.79% |
CME | -5.26% | $99.01B | +39.76% | 3.87% |
CYCN | -4.77% | $9.63M | +30.43% | 0.00% |
VSTA | -4.74% | $342.46M | +40.00% | 0.00% |
LITB | -3.37% | $21.70M | -78.27% | 0.00% |
HUSA | -3.04% | $22.94M | -6.82% | 0.00% |
NGVC | -2.06% | $900.11M | +85.00% | 1.17% |
DFDV | -1.94% | $247.94M | +1,821.34% | 0.00% |
K | -1.94% | $27.41B | +36.96% | 2.88% |
LRN | -1.91% | $6.34B | +106.55% | 0.00% |
STG | -1.12% | $29.06M | -28.79% | 0.00% |
CNK | -1.10% | $3.46B | +39.22% | 0.53% |
PPC | -0.77% | $10.57B | +30.66% | 0.00% |
BTCT | 0.20% | $18.98M | +37.85% | 0.00% |
TGI | 0.35% | $2.00B | +67.36% | 0.00% |
VSA | 0.55% | $8.67M | -15.70% | 0.00% |
CCRN | 0.71% | $419.30M | -7.59% | 0.00% |
VHC | 0.99% | $45.90M | +59.26% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IBTM | -0.20% | $316.18M | 0.07% |
SMB | -0.21% | $274.71M | 0.07% |
FMF | -0.48% | $155.81M | 0.95% |
IBTL | -0.57% | $380.68M | 0.07% |
SMMU | 0.69% | $888.13M | 0.35% |
AGZ | 0.84% | $614.02M | 0.2% |
USDU | -0.87% | $162.92M | 0.5% |
AGZD | -0.89% | $102.66M | 0.23% |
BNDX | -0.92% | $67.37B | 0.07% |
UDN | -0.96% | $147.88M | 0.78% |
TYA | 0.96% | $152.19M | 0.15% |
BSV | 1.02% | $38.37B | 0.03% |
SHV | 1.06% | $20.67B | 0.15% |
UUP | 1.10% | $211.55M | 0.77% |
SPTI | -1.10% | $8.78B | 0.03% |
SHY | 1.11% | $24.08B | 0.15% |
BILZ | 1.17% | $827.49M | 0.14% |
SCHR | -1.21% | $11.12B | 0.03% |
FXE | -1.72% | $568.58M | 0.4% |
IBMN | -1.77% | $446.95M | 0.18% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TMO | 80.62% | $154.12B | -26.17% | 0.40% |
A | 74.06% | $33.85B | -8.07% | 0.81% |
TECH | 71.49% | $8.13B | -27.65% | 0.62% |
MTD | 70.67% | $24.62B | -15.24% | 0.00% |
RVTY | 70.05% | $11.53B | -6.71% | 0.29% |
BIO | 69.19% | $6.64B | -10.67% | 0.00% |
IQV | 67.46% | $27.24B | -25.53% | 0.00% |
RGEN | 66.67% | $6.94B | -1.98% | 0.00% |
ASH | 64.73% | $2.32B | -46.34% | 3.21% |
BRKR | 63.89% | $6.33B | -34.49% | 0.48% |
QGEN | 62.78% | $10.34B | +13.03% | 0.00% |
DOW | 61.98% | $19.09B | -49.10% | 10.47% |
WAT | 61.57% | $20.97B | +21.47% | 0.00% |
TXT | 61.30% | $14.50B | -6.43% | 0.10% |
MSCI | 60.96% | $44.60B | +19.65% | 1.18% |
DD | 60.45% | $28.83B | -14.42% | 2.30% |
LYB | 60.16% | $18.86B | -38.67% | 9.26% |
PNR | 60.09% | $17.04B | +35.10% | 0.93% |
AVTR | 59.32% | $9.22B | -36.18% | 0.00% |
NDSN | 59.09% | $12.16B | -7.25% | 1.45% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAIL | -50.86% | $99.76M | 0.59% |
VIXY | -46.86% | $165.69M | 0.85% |
BTAL | -31.39% | $296.79M | 1.43% |
IVOL | -30.10% | $349.27M | 1.02% |
CLIP | -26.80% | $1.52B | 0.07% |
FTSD | -17.93% | $231.79M | 0.25% |
TPMN | -15.70% | $30.81M | 0.65% |
SHYM | -15.05% | $350.04M | 0.35% |
XONE | -15.00% | $585.86M | 0.03% |
XHLF | -14.58% | $1.73B | 0.03% |
FXY | -14.00% | $815.67M | 0.4% |
STPZ | -12.75% | $450.22M | 0.2% |
SPTS | -12.73% | $5.78B | 0.03% |
GBIL | -10.77% | $6.38B | 0.12% |
UTWO | -9.84% | $379.36M | 0.15% |
SCHO | -9.06% | $11.46B | 0.03% |
VGSH | -8.66% | $22.80B | 0.03% |
CORN | -8.63% | $44.21M | 0.2% |
IBTH | -8.24% | $1.60B | 0.07% |
TFLO | -7.99% | $6.83B | 0.15% |
Current Value
$198.921 Year Return
Current Value
$198.921 Year Return